GPAT logo

GP-Act III Acquisition Corp. (GPAT)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

GP-Act III Acquisition Corp. (GPAT) trades at $10.83 with AI Score 50/100 (Hold). GP-Act III Acquisition Corp. is a shell company seeking a merger, share exchange, asset acquisition, or similar business combination. Market cap: 390M, Sector: Financial services.

Last analyzed: Feb 8, 2026
GP-Act III Acquisition Corp. is a shell company seeking a merger, share exchange, asset acquisition, or similar business combination. Incorporated in 2020, the company aims to identify and partner with a promising business to bring to the public market.
50/100 AI Score MCap 390M Vol 515K

GP-Act III Acquisition Corp. (GPAT) Financial Services Profile

CEOAntonio Carlos Augusto Ribeiro Bonchristiano
Employees2
HeadquartersNew York City, NY, US

GP-Act III Acquisition Corp. offers investors a unique opportunity to participate in a future merger or acquisition, leveraging a seasoned management team to identify and capitalize on high-growth potential businesses, operating with a lean structure and a market cap of $0.39 billion.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Investing in GP-Act III Acquisition Corp. presents a speculative opportunity centered on the potential acquisition of a high-growth business. With a market capitalization of $0.39 billion and a P/E ratio of 25.08, the company's valuation is tied to its ability to identify and merge with a promising target. Key value drivers include the management team's expertise in deal sourcing and execution, as well as the attractiveness of the target company. Upcoming catalysts include the announcement of a definitive merger agreement, which would likely drive significant stock price movement. The investment thesis relies on the successful completion of a value-accretive transaction within the next 12-24 months, offering investors exposure to a potentially high-growth business that may not otherwise be accessible through public markets.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.39 billion reflects investor expectations for a successful merger.
  • P/E ratio of 25.08 indicates the market's current valuation of the company's earnings potential upon completion of a merger.
  • Beta of 0.05 suggests low volatility relative to the broader market, typical for SPACs awaiting a merger announcement.
  • The company has 2 employees, indicating a lean operational structure focused on deal execution.
  • No dividend yield reflects the company's focus on growth through acquisitions rather than returning capital to shareholders.

Competitors & Peers

Strengths

  • Experienced management team with a track record of successful deal-making.
  • Access to capital through public markets.
  • Flexibility to pursue a wide range of acquisition targets.
  • Lean operational structure with low overhead costs.

Weaknesses

  • Dependence on identifying and completing a successful merger.
  • Limited operating history as a standalone entity.
  • Potential for conflicts of interest between management and shareholders.
  • Dilution of shareholder value through management fees and equity.

Catalysts

  • Upcoming: Announcement of a definitive merger agreement with a target company.
  • Upcoming: Completion of the merger and integration of the acquired business.
  • Ongoing: Positive market sentiment towards SPACs and merger activity.
  • Ongoing: Management team's ability to identify and secure attractive acquisition targets.

Risks

  • Potential: Inability to identify and complete a merger within the specified timeframe, leading to liquidation of the company.
  • Potential: Failure to obtain shareholder approval for the proposed merger.
  • Potential: Overpayment for the acquired company, resulting in diminished shareholder value.
  • Ongoing: Economic downturn or market volatility that could negatively impact the acquired company's performance.
  • Ongoing: Regulatory changes that could impact the SPAC market or the acquired company's industry.

Growth Opportunities

  • Successful Merger Completion: The primary growth opportunity lies in successfully completing a merger with a high-growth target company. The market size for potential acquisition targets spans various industries, offering GP-Act III Acquisition Corp. a broad range of options. A successful merger would unlock significant value for shareholders, driven by the target company's growth prospects and potential synergies. Timeline: Within the next 12-24 months.
  • Operational Synergies: Post-merger, there is an opportunity to unlock operational synergies between GP-Act III Acquisition Corp. and the acquired company. This could involve streamlining operations, reducing costs, and leveraging shared resources to improve profitability. The potential market size for cost savings and efficiency gains is substantial, depending on the nature of the acquired business. Timeline: 1-3 years post-merger.
  • Capital Deployment: GP-Act III Acquisition Corp. has the opportunity to deploy its capital effectively to support the growth of the acquired company. This could involve investing in research and development, expanding into new markets, or making strategic acquisitions. The potential market size for growth investments is significant, depending on the industry and growth strategy of the acquired company. Timeline: Ongoing post-merger.
  • Management Expertise: The management team's expertise in deal sourcing and execution provides a competitive advantage in identifying and securing attractive acquisition targets. Their experience in negotiating favorable terms and integrating acquired businesses can drive significant value creation for shareholders. The market size for successful deal-making is substantial, as evidenced by the high valuations of companies that have successfully completed mergers and acquisitions. Timeline: Ongoing.
  • Access to Public Markets: By taking a private company public through a merger, GP-Act III Acquisition Corp. provides the acquired company with access to public markets and a broader investor base. This can facilitate future capital raises and enhance the company's visibility and credibility. The potential market size for public market financing is significant, depending on the capital needs of the acquired company. Timeline: Post-merger.

Opportunities

  • Growing demand for SPACs as an alternative to traditional IPOs.
  • Increasing number of private companies seeking to go public.
  • Potential to acquire a high-growth company at an attractive valuation.
  • Opportunity to unlock synergies and create value through operational improvements.

Threats

  • Increased competition from other SPACs.
  • Regulatory changes that could impact the SPAC market.
  • Economic downturn that could reduce the number of attractive acquisition targets.
  • Inability to complete a merger within the specified timeframe.

Competitive Advantages

  • Management team's expertise in deal sourcing and execution.
  • Access to capital through public markets.
  • Ability to provide private companies with a path to go public.
  • Established network of relationships with potential target companies and investors.

About GPAT

GP-Act III Acquisition Corp., established in 2020 and based in New York City, operates as a special purpose acquisition company (SPAC). Formerly known as GP Investments Acquisition Corp. II, the company's core mission is to identify and merge with a private company, effectively taking it public without the traditional IPO process. This involves seeking a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company's evolution reflects the broader SPAC market trends, where entities are formed specifically to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. GP-Act III Acquisition Corp. provides a vehicle for investors to participate in potential high-growth opportunities, guided by a management team with expertise in deal-making and value creation. With only 2 employees, the company maintains a lean operational structure, focusing its resources on identifying and executing a successful business combination. The ultimate success of GP-Act III Acquisition Corp. hinges on its ability to find an attractive target company and complete a transaction that delivers value to its shareholders.

What They Do

  • Identify potential merger targets.
  • Negotiate merger agreements.
  • Raise capital through public markets.
  • Complete a business combination with a target company.
  • Take a private company public.
  • Provide investors with access to potential high-growth opportunities.

Business Model

  • Raise capital through an initial public offering (IPO).
  • Seek a merger, share exchange, asset acquisition, or similar business combination.
  • Generate returns for investors through the appreciation of the acquired company's stock price.
  • Management team receives compensation and equity based on the successful completion of a merger.

Industry Context

GP-Act III Acquisition Corp. operates within the shell company industry, a segment of the financial services sector characterized by special purpose acquisition companies (SPACs). The SPAC market has experienced significant growth in recent years, driven by a desire for companies to go public faster and with less regulatory scrutiny than traditional IPOs. The competitive landscape includes numerous SPACs, each vying to identify and merge with attractive target companies. GP-Act III Acquisition Corp. must differentiate itself through its management team's expertise, deal sourcing capabilities, and ability to negotiate favorable terms.

Key Customers

  • Institutional investors seeking exposure to potential high-growth companies.
  • Retail investors interested in participating in merger and acquisition opportunities.
  • Private companies seeking to go public without the traditional IPO process.
AI Confidence: 72% Updated: Feb 8, 2026

Financials

Chart & Info

GP-Act III Acquisition Corp. (GPAT) stock price: $10.83 (+0.03, +0.28%)

Latest News

No recent news available for GPAT.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GPAT.

Price Targets

Wall Street price target analysis for GPAT.

MoonshotScore

50/100

What does this score mean?

The MoonshotScore rates GPAT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About GPAT

What does GP-Act III Acquisition Corp. do?

GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC), also known as a blank check company. It is designed to raise capital through an initial public offering (IPO) with the sole purpose of acquiring an existing private company. The company does not have any specific business operations of its own but seeks to identify and merge with a promising business, effectively taking it public. Investors are betting on the management team's ability to find a valuable target and negotiate a successful merger, providing a potentially faster and less regulated path to the public market for the acquired company.

Is GPAT stock worth researching?

Evaluating GPAT stock requires considering the speculative nature of SPAC investments. With a market cap of $0.39 billion and a P/E ratio of 25.08, the stock's value is heavily dependent on the successful identification and acquisition of a high-growth target. Potential investors should assess the management team's expertise, the attractiveness of potential target industries, and the overall market conditions for mergers and acquisitions. While the potential upside can be significant, the risk of liquidation if a merger is not completed should also be carefully considered.

What are the main risks for GPAT?

The primary risk for GPAT is the inability to identify and complete a merger within the specified timeframe, typically two years. If a merger is not completed, the company will be forced to liquidate, and investors may receive only a fraction of their initial investment. Other risks include overpaying for the acquired company, failing to obtain shareholder approval for the merger, and economic downturns that could negatively impact the acquired company's performance. Regulatory changes impacting the SPAC market also pose a potential risk.

What are the key factors to evaluate for GPAT?

GP-Act III Acquisition Corp. (GPAT) currently holds an AI score of 50/100, indicating moderate score. The stock trades at a P/E of 25.3x, near the S&P 500 average (~20-25x). Key strength: Experienced management team with a track record of successful deal-making.. Primary risk to monitor: Potential: Inability to identify and complete a merger within the specified timeframe, leading to liquidation of the company.. This is not financial advice.

How frequently does GPAT data refresh on this page?

GPAT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven GPAT's recent stock price performance?

Recent price movement in GP-Act III Acquisition Corp. (GPAT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Experienced management team with a track record of successful deal-making.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider GPAT overvalued or undervalued right now?

Determining whether GP-Act III Acquisition Corp. (GPAT) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 25.3. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying GPAT?

Before investing in GP-Act III Acquisition Corp. (GPAT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • The analysis is based on publicly available information and limited company disclosures.
  • The success of GP-Act III Acquisition Corp. is highly dependent on the management team's ability to execute a successful merger.
  • SPAC investments are inherently speculative and involve a high degree of risk.
Data Sources

Popular Stocks